Evidence map›Paper›PMID 39027256›Full record

ArticleActa pharmaceutica Sinica. B2024

KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2.

Chaofan Peng, Peng Yang, Dongsheng Zhang, Chi Jin, Wen Peng, Tuo Wang, Qingyang Sun, Zhihao Chen, Yifei Feng, Yueming Sun

Abstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Beyond fructolysis: ketohexokinase orchestrates ER proteostasis in nutrient-stressed hepatocytes.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chaofan PengDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Peng YangDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Dongsheng ZhangDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Chi JinDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Wen PengDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Tuo WangDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Qingyang SunDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhihao ChenDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yifei FengDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yueming SunDepartment of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive fructose diet is closely associated with colorectal cancer (CRC) progression. Nevertheless, fructose's specific function and precise mechanism in colorectal cancer liver metastasis (CRLM) is rarely known. Here, this study reported that the fructose absorbed by primary colorectal cancer could accelerate CRLM, and the expression of KHK-A, not KHK-C, in liver metastasis was higher than in paired primary tumors. Furthermore, KHK-A facilitated fructose-dependent CRLM

Indexed as

CRCCRLMFructoseKHK-APKM2

Identifiers

PMID39027256
PMCPMC11252482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.